lobbying_activities: 2877055

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id filing_uuid filing_type registrant_name registrant_id client_name filing_year filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
2877055 41469878-f787-42ec-855c-7f0218a29524 3A TOBACCO-FREE KIDS ACTION FUND 401106380 TOBACCO-FREE KIDS ACTION FUND 2022 third_quarter TOB Lobbying Report: July 1 - September 30, 2022 (Action Fund) Legislation: H.R. 8239 House FY 2023 Appropriations for the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies (Lobbying activities related to FY 2023 appropriations for the Food and Drug Administration and regulation of tobacco products) H.R. 8294 FY 2023 Consolidated Appropriations Act (Lobbying activities related to FY 2023 appropriations for the Food and Drug Administration and regulation of tobacco products) H.R. 8295 House FY 2023 Appropriations for the Departments of Labor, Health and Human Services, and Education, and Related Agencies (Lobbying activities related to FY 2023 appropriations for the Centers for Disease Control and Prevention) Senate FY 2023 Appropriations for the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies (Lobbying activities related to FY 2022 appropriations for the Food and Drug Administration and regulation of tobacco products) H.R. 5376 Inflation Reduction Act of 2022 Senate FY 2023 Appropriations for the Departments of Labor, Health and Human Services, and Education, and Related Agencies (Lobbying activities related to FY 2023 appropriations for the Centers for Disease Control and Prevention) H.R. 2125 Quit Because of COVID-19 Act H.R. 8202 Preventing Vape Use Act Issues FDA action to address synthetic nicotine FDA premarket review of e-cigarettes FDAs proposed rules on menthol cigarettes and flavored cigars Medicaid and tobacco cessation Reducing nicotine levels in cigarettes Tobacco cessation in general Tobaccos role in health disparities Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   190000 0 0 2022-10-19T13:52:20-04:00